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Background. Bipolar disorder (BD) has been reported to be associated with high risk of suicide. We aimed to investigate
the frequency and characteristics of suicide in people with BD in a national sample.
Method. Suicide in BD in England from 1996 to 2009 was explored using descriptive statistics on data collected by
the National Confidential Inquiry into Suicide and Homicide by People with Mental Illness (NCI). Suicide cases with
a primary diagnosis of BD were compared to suicide cases with any other primary diagnosis.
Results. During the study period 1489 individuals with BD died by suicide, an average of 116 cases/year. Compared to
other primary diagnosis suicides, those with BD were more likely to be female, more than 5 years post-diagnosis, current/
recent in-patients, to have more than five in-patient admissions, and to have depressive symptoms. In BD suicides the
most common co-morbid diagnoses were personality disorder and alcohol dependence. Approximately 40% were not
prescribed mood stabilizers at the time of death. More than 60% of BD suicides were in contact with services the
week prior to suicide but were assessed as low risk.
Conclusions. Given the high rate of suicide in BD and the low estimates of risk, it is important that health professionals
can accurately identify patients most likely to experience poor outcomes. Factors such as alcohol dependence/misuse,
personality disorder, depressive illness and current/recent in-patient admission could characterize a high-risk group.
Future studies need to operationalize clinically useful indicators of suicide risk in BD.
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Introduction
Suicide is a major cause of premature mortality world-
wide and its prevention is a clinical and policy priority.
Individuals with bipolar disorder (BD) are thought to
be at particularly high risk and it has been suggested
that between 12% and 19% of people diagnosed with
BD die by suicide (Guze & Robins, 1970; Goodwin
& Jamison, 1990; Harris & Barraclough, 1997). How-
ever, data from more recent studies have cast some
doubt on the validity of these figures. Estimates of sui-
cide incidence have tended to be lower (Tondo et al.
2003; Rihmer, 2005), possibly as a consequence of
changes in diagnostic criteria over time, the inclusion
of bipolar subtypes and less focus on in-patient
populations. In a study of absolute risk of suicide
after hospital contact for mental disorder, Nordentoft
et al. (2011) followed up individuals over 36 years
and found that the highest risk was among men with
BD: 8% died by suicide during the follow-up period.
For women with BD the risk was 5% and was the sec-
ond highest risk group behind only schizophrenia.
These figures are similar to those presented by Angst
et al. (2002), who found that 8% of people with BD
died by suicide over a follow-up period of more than
40 years. In a review of studies of suicide by individ-
uals with a current major depressive episode, Rihmer
(2005) reported that 44% may have had a diagnosis
of bipolar II disorder (BD II). In two prospective
studies, Tondo et al. (2003, 2007) found that the rate
of suicide in BD was 0.25%/year and 0.4%/year respect-
ively. The lack of consensus is likely to be a conse-
quence of the different methodologies used in these
studies. Accurately estimating the rate of suicide in
BD is further complicated by the continuing opacity
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of the prevalence of BD itself, with estimates ranging
from 0.5% to 2.4% in studies of the general population
(Mitchell et al. 2004; Merikangas et al. 2007, 2011; Lee
et al. 2009), and could be as high as 3–4% for BD II
(Merikangas & Lamers, 2012). Perhaps unsurprisingly,
given this context, few studies have examined tem-
poral trends in BD suicides.
Several studies have sought to identify which bi-
polar patients are most at risk of suicide but results
have proved limited and contradictory. Marangell
et al. (2006) carried out a prospective study of bipolar
patients in the USA and found that history of suicide
attempt and percentage days depressed in the previous
year were related to subsequent suicidal behaviour.
Other studies have also identified history of suicide
attempt as a risk factor for suicide in BD (Rihmer,
2007), along with male gender (Hawton et al. 2005)
and expressed hopelessness (Tondo et al. 2003). How-
ever, these characteristics are also common in general
population suicides and are therefore unlikely to be
related specifically to a diagnosis of BD.
Previous work has been subject to several method-
ological limitations; studies have typically recruited
small samples, included few events, or have been car-
ried out within a single treatment centre or geographi-
cal area (Tondo et al. 2003; Hawton et al. 2005).
Research on incidence and rates of suicide in BD has
often been restricted to a specific bipolar subtype or
more seriously ill hospitalized patients (Baldessarini
& Jamison, 1999; Fagiolini et al. 2004). Follow-up
periods are often short and might distort the risk of
suicide in BD as risk may be increased in the early
stages of BD and diagnoses may change over time
(for example, bipolar is often misdiagnosed initially
as unipolar depression) (Goodwin & Jamison, 1990).
The prevention of suicide, particularly among high-
risk groups such as those with mental illness, is an im-
portant public health aim in many countries (US Public
Health Service, 1999; Department of Health, 2002).
Reliable baseline statistics are essential in tracking
progress but the comparative lack of good quality
international data on suicide in BD makes it difficult
to assess the impact of suicide prevention strategies
in this group. More reliable estimates of the frequency
of suicide in BD and further clarification of the key
characteristics associated with suicide in BD would
be of use to clinicians, service providers and policy
makers.
Aims
The aim of this study was to describe the frequency,
trends over time, and characteristics of those with BD
who died by suicide in England, using data from a
large national database. The specific objectives were
to: (1) describe the frequency of suicide in BD in a clini-
cal population; (2) identify any trends over time in the
number of bipolar suicide deaths; and (3) describe the
demographic, clinical and management characteristics
of people with a primary diagnosis of BD who died
by suicide, and to compare them to suicides by people
with other primary diagnoses.
Method
The National Confidential Inquiry into Suicide and
Homicide by People with Mental Illness (NCI)
Our analyses used data from the suicide database
of the NCI (Appleby et al. 2006; Hunt et al. 2006).
Data collection by the NCI involves three stages. In
stage 1 the NCI collects basic information on a com-
plete national sample of suicide deaths and deaths
that have received an open verdict at coroner’s inquest
for all individuals aged 510 years, from the Office for
National Statistics (ONS) for England and Wales. It
is convention in the UK to include open verdicts in
official statistics and research studies, as the majority
of these are suicide deaths (O‘Donnell & Farmer,
1995), and excluding cases given open verdicts may
result in a 50% underestimate in the incidence of sui-
cide (Linsley et al. 2001). All open verdicts are included
unless there is a clear record that suicide was not con-
sidered as a cause of death at inquest. In stage 2 the
NCI identifies suicides that were in contact with men-
tal health services in the 12 months prior to death by
contacting hospitals and community trusts providing
these services in the deceased’s district of residence.
If records show the deceased was in contact with
services, they become an ‘inquiry case’. In stage 3,
for all ‘inquiry cases’, the consultant psychiatrist
responsible for the care of the patient is identified
and sent a copy of the NCI suicide questionnaire to
complete. The suicide questionnaire collects informa-
tion on social/demographic characteristics, clinical his-
tory, details of the suicide, details of care and final
contact with services, and the respondents’ views on
prevention.
Data from returned suicide questionnaires are
entered onto the NCI suicide database, which includes
data on inquiry cases from 1996 onwards. The NCI sui-
cide questionnaire has a response rate of more than
97% (Appleby et al. 2012) and has been shown to be
a reliable data collection tool (Windfuhr et al. 2008).
NCI BD sample
Unless stated otherwise, the BD suicide sample used in
the analyses includes all cases on the NCI suicide data-
base with a primary diagnosis of BD from England.
Primary and secondary diagnoses are collected
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routinely as part of the NCI suicide questionnaire.
Primary diagnosis is considered to be the ‘main’
psychiatric diagnosis and is determined by the respond-
ing clinician. Diagnostic categories are concordant
with ICD-10 classifications. Therefore, the diagnostic
group ‘bipolar disorder’ on the NCI suicide database
encompasses the same groups as the ICD-10 BD
category (F31) and includes BD I, BD II, and BD not
otherwise specified (NOS). Respondents may use a
combination of case-note review, consultation with
other members of the mental health team and clinical
judgement based on their own knowledge of the
patient in reporting primary and secondary diagnoses.
Analysis
All statistical analyses were conducted using SPSS 15.0
for Windows (SPSS Inc., USA), apart from trend tests,
which were carried out using Stata/IC 11.0 for win-
dows (StataCorp LP, USA).
Trends
Poisson regression was used to carry out trend tests for
significant increases or decreases in BD suicides over
time. Tests were run for the whole NCI bipolar sample
and separately for males, females and age groups (the
four age groups were those commonly used in the
work of the NCI: 424, 25–44, 45–64 and 565 years).
We also formally tested for interaction between bipolar
and general population suicide deaths, and between
different age groups for the bipolar sample.
Characteristics of suicide in BD
Simple descriptive statistics were used to describe the
demographic, treatment and clinical characteristics of
the bipolar suicides. Items were compared between
BD suicides and other primary diagnosis suicides.
Any cases with unknown items were removed from
the analysis of that item; therefore, the denominator
in each analysis is the number of valid cases for each
item. The number of valid responses included for
each item are displayed as a percentage of the total
number of cases. Where possible, variables were com-
bined to create more comprehensive categories and to
reduce the proportion of missing data (e.g. individual
antidepressant categories were combined to create
a single antidepressant variable). Pearson’s χ2 tests of
association were used, for two by two tables the con-
tinuity correction is given, odds ratios (ORs) and as-
sociated 95% confidence intervals (CIs) are also
presented. Because multiple testing was used, a
p value of 0.01 was selected to assess statistical signifi-
cance. Age and gender were regarded as possible
explanatory variables rather than confounders and so
were not adjusted for in the primary analyses; how-
ever, secondary analyses adjusting all ORs for age
and gender were carried out.
Results
There were 1489 BD suicides in our sample. This rep-
resented just less than 10% of all suicide deaths on
the NCI database for the study period (9.6% of 15465
valid cases). The average number of BD suicides per
year between 1997 and 2007 (when data were most
complete) was 116. The average frequency of BD sui-
cide per year was 65 for males and 52 for females.
Trends over time
There were no significant trends in the frequency of BD
suicides over time [incidence rate ratio (IRR) 0.99, 95%
CI 0.97–1.00, p=0.15] whereas general population sui-
cides over the same time period decreased significantly
(IRR 0.98, 95% CI 0.98–0.98, p<0.01). There was no
significant increase or decrease in frequency of BD sui-
cides for females (IRR 1, 95% CI 0.97–1.02, p=0.79) or
males (IRR 0.98, 95% CI 0.96–1.00, p=0.08). A test of
interaction between BD suicides and all other suicides
in the general population was not significant (χ2=0.13,
df=1, p=0.72), suggesting that the failure to detect
significant falls in suicide in the bipolar sample could
have been due to smaller numbers. With respect to
age, trend tests showed significant downward trends
in the frequency of suicide for the under-24 age
group (IRR 0.84, 95% CI 0.77–0.93, p<0.001) and the
25–44 age group (IRR 0.97, 95% CI 0.94–0.99, p=
0.015). There were no significant trends in the older
age groups. A test of interaction confirmed that the
decline in suicides over time was significantly different
between age groups (χ2=18.3, df=3, p<0.001).
Characteristics of the sample
Demographics and secondary diagnoses
Table 1 shows the demographic and diagnostic charac-
teristics of BD suicides compared to other primary diag-
nosis suicides. BD suicides were older and less likely to
bemale. BD suicides were less likely than other primary
diagnosis suicides to have several characteristics that are
known risk factors for suicide (e.g. homelessness and a
history of previous suicidal behaviour). BD suicides
were more likely to have had their primary diagnosis
for more than 5 years. Overall, those with BD were less
likely than other patients to have a formal secondary
diagnosis (particularly those related to depression or
anxiety). The most common secondary diagnoses in
thosewith BDwhodied by suicidewere personality dis-
order and alcohol dependence, together accounting for
nearly one-fifth of cases.
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Table 1. Demographic and clinical characteristics for suicides with a primary diagnosis of bipolar disorder (BD) compared to suicides with any
other primary diagnosis







n (%) OR (95% CI) p value
Age group (98)
424 years 57 (3.8) 1106 (8.1) 0.45 (0.35–0.59) <0.01
25–44 years 641 (43.0) 6297 (46.0) 0.89 (0.80–0.99)
45–64 years 635 (42.6) 4574 (33.4) 1.48 (1.33–1.65)
565 years 156 (10.5) 1701 (12.4) 0.82 (0.69–0.98)
Male (98) 833 (55.9) 9113 (66.6) 0.64 (0.57–0.71) <0.01
Ethnic origin (93)
White 1373 (93.2) 12446 (93.0) 1.03 (0.84–1.28) 0.17
Black African/Caribbean 23 (1.6) 289 (2.2) 0.72 (0.47–1.10)
Indian/Pakistani/Bangladeshi 43 (2.9) 302 (2.3) 1.30 (0.94–1.80)
Chinese 2 (0.1) 26 (0.2) 0.70 (0.17–2.95)
Marital status (96)
Married or cohabiting 469 (31.8) 3976 (29.6) 1.11 (0.99–1.24) <0.01
Single or divorced 935 (63.3) 8537 (63.6) 0.99 (0.89–1.11)
Widowed 72 (4.9) 909 (6.8) 0.71 (0.55–0.90)
Employment status (94)
Employed 268 (18.3) 2479 (18.8) 0.97 (0.84–1.11) <0.01
Unemployed 547 (37.4) 5481 (41.6) 0.84 (0.75–0.94)
Other 649 (44.3) 5228 (39.6) 1.21 (1.09–1.35)
Living arrangements (94)
Living alone 667 (45.4) 5596 (42.2) 1.09 (0.98–1.21) <0.01
Living with family 660 (44.9) 6119 (46.2) 0.94 (0.84–1.05)
Homeless 14 (1.0) 271 (2.0) 0.43 (0.26–0.71)
Other 128 (8.7) 1269 (9.6) 0.94 (0.70–1.14)
Previous self-harm (96) 938 (63.9) 9039 (67.3) 0.86 (0.77–0.97) 0.01
History of violence (95) 314 (21.4) 2754 (20.7) 1.04 (0.91–1.19) 0.59
Method of suicide (96)
Self-poisoning 394 (26.6) 3885 (28.6) 0.90 (0.80–1.01) <0.01
Hanging 527 (35.6) 4973 (36.6) 0.95 (0.85–1.06)
Jumping 263 (17.8) 1974 (14.5) 1.26 (1.10–1.46)
Other 295 (19.9) 2766 (20.3) 0.98 (0.85–1.12)
Duration of primary diagnosis (97)
<1 year 147 (9.9) 2887 (21.5) 0.40 (0.34–0.48) <0.01
1–5 years 276 (18.6) 3793 (28.2) 0.58 (0.51–0.67)
>5 years 1057 (71.4) 6766 (50.3) 2.47 (2.19–278)
Secondary diagnoses (96)
BD 0 89 (0.7) – <0.01
Depressive illness 70 (4.8) 1675 (12.4) 0.35 (0.28–0.45)
Anxiety/phobia/panic disorder/OCD 44 (3.0) 1125 (8.3) 0.30 (0.25–0.46)
Alcohol dependence 116 (7.9) 974 (7.2) 1.11 (0.91–1.35)
Drug dependence 51 (3.5) 642 (4.8) 0.72 (0.54–0.97)
Personality disorder 143 (9.8) 1174 (8.7) 1.14 (0.95–1.36)
Adjustment disorder 28 (1.9) 550 (4.1) 0.46 (0.31–0.67)
Alcohol misuse but not dependence 59 (4.0) 526 (3.9) 1.04 (0.79–1.36)
Drug misuse but not dependence 31 (2.1) 307 (2.3) 0.93 (0.64–1.35)
Other 48 (3.3) 507 (3.8) 0.87 (0.64–1.17)
No secondary diagnosis 874 (59.7) 5927 (43.9) 1.89 (1.70–2.11)
OCD, Obsessive–compulsive disorder; OR, odds ratio; CI, confidence interval.
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Care and management characteristics (Table 2)
Compared to other primary diagnosis suicides, BD
suicides were more likely to have been current or
recent in-patients and to have had more than five
previous admissions to in-patient care. BD suicides
were less likely than other primary diagnosis suicides
to be in contact with drug and alcohol services. BD
suicides were slightly more likely to be prescribed
typical or atypical antipsychotic drugs than the com-
parison group, and much more likely to have been
prescribed lithium or other mood stabilizers.
Overall, just over half of BD suicides had been pre-
scribed mood stabilizers. Of those prescribed mood
stabilizers who died by self-poisoning (179, 27.4%),
the overdose included these drugs in only 25 (14.0%)
cases.
Clinical characteristics at last contact before suicide
(Table 3)
BD suicides were more likely to have been seen by
mental health services in the 7 days prior to suicide
than those with other primary diagnoses. BD suicides
were also more likely to have evidence of depressive
symptoms at last contact, but less likely than those
with other primary diagnosis to have evidence of hos-
tility at last contact. The majority of cases across both
groups were considered to be at low or no immediate
risk of suicide.
When we adjusted the ORs in Tables 1–3 for age and




This study describes the largest detailed sample of sui-
cide deaths by individuals with BD in the international
literature to date. In our sample nearly 10% of current
psychiatric patients who died by suicide had a primary
diagnosis of BD. Trend tests suggest that the decline in
BD suicide deaths was not statistically significant but
this could have been due to small numbers. There
was some evidence of a decrease in the number of
BD suicide deaths by younger patients.
There was a higher proportion of females among BD
suicides than among other primary diagnosis suicides.
BD suicides were more than twice as likely as those
with other primary diagnoses to have been diagnosed
more than 5 years prior to the suicide. Demographic
and social factors among those with BD showed little
difference compared with those with other primary
diagnoses. Personality disorder and alcohol depen-
dence were the most common secondary diagnoses
in the BD group. BD suicides had a distinct pattern
in relation to accessing in-patient care and just less
than half were current or recent in-patients at the
Table 2. Treatment characteristics for suicides with a primary diagnosis of bipolar disorder (BD) compared to suicides with any other primary
diagnosis









n (%) OR (95% CI) p value
In-patient at time of suicide (98) 286 (19.2) 1835 (13.4) 1.54 (1.34–1.76) <0.01
Suicide within 3 months of discharge from in-patient care (84) 339 (28.2) 2772 (23.4) 1.28 (1.12–1.47) <0.01
One to five previous admissions to in-patient care (94) 828 (57.2) 7574 (57.6) 0.98 (0.88–1.10) 0.78
More than five admissions to in-patient care (94) 469 (32.4) 1754 (13.3) 3.11 (2.76–3.51) <0.01
ECT (76) 12 (1.1) 73 (0.7) 1.53 (0.83–2.83) 0.24
Seeing drug and/or alcohol services (94)a 39 (5.9) 701 (11.9) 0.47 (0.33–0.65) <0.01
Receiving psychological treatment (74) 169 (15.0) 1660 (16.0) 0.92 (0.78–1.10) 0.38
Prescribed oral typical antipsychotic drugs (73) 205 (18.3) 1285 (12.6) 1.55 (1.32–1.83) <0.01
Prescribed oral atypical antipsychotic drugs (73) 435 (38.9) 2683 (26.3) 1.78 (1.57–2.03) <0.01
Prescribed lithium or mood stabilizer (73) 654 (58.2) 707 (6.9) 18.77 (16.30–21.62) <0.01
Prescribed any antidepressant (71) 704 (60.0) 6606 (66.1) 0.77 (0.68–0.87) <0.01
Non-compliant with medication in the month before death (87) 254 (18.2) 2105 (17.2) 1.07 (0.93–1.24) 0.38
ECT, Electro-convulsive therapy; OR, odds ratio; CI, confidence interval.
a Question added to National Confidential Inquiry into Suicide and Homicide by People with Mental Illness (NCI)
questionnaire in 2003; only cases where year of death was 2003 or later were included in the analysis (sample comprised
660 BD diagnosis, n=5896 all other diagnosis).
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time of the suicide. Most had previously been admitted
to in-patient care and were three times more likely than
those with other primary diagnosis to have had more
than five previous in-patient admissions. Mood stabil-
izers were the most commonly prescribed pharmaco-
logical treatment for those with BD; however, given
the possible anti-suicidal properties of lithium
(Baldessarini et al. 2006), an important finding was
that more than 40% of cases were not prescribed
mood stabilizers. Data for this variable were not com-
plete (73% complete). This finding should therefore be
interpreted cautiously, although we suspect that those
not prescribed mood stabilizers would be over-
represented in the missing data group. In this case
the proportion of individuals not prescribed appropri-
ate medication might be even higher. Just over 60% of
patients with BD had been in contact with mental
health services in the 7 days prior to the suicide, and
just under half of these were seen within 24 hours of
the suicide. Almost 90% of BD suicides were assessed
as being at no or low immediate risk of suicide when
they were seen (although this was not dissimilar to
those with other primary diagnoses).
Findings in relation to previous research
The results of this study are consistent with previous
research on factors found to be associated with com-
pleted suicide in BD (Dalton et al. 2003; Leverich
et al. 2003; Tondo et al. 2003; Rihmer, 2009). Our data
confirm that suicide in BD is associated with a high
number of previous admissions to in-patient care
(Leverich et al. 2003), although the reasons for admis-
sion were not available. The number of bipolar cases
with substance misuse (Lopez et al. 2001; Tondo et al.
2003; Oquendo & Mann, 2006) and/or anxiety disorder
(Angst et al. 2002; Leverich et al. 2003; Simon et al. 2007)
was lower than might have been expected given the
prevalence of co-morbid substance and anxiety dis-
orders typically found in BD populations (Goodwin
& Jamison, 1990). It is possible that this was a record-
ing bias. However, our study was restricted to a clini-
cal subgroup of people with BD who died by suicide
and previous work has suggested that substance/
alcohol use is not strongly related to suicide in these
individuals (Hawton et al. 2005). We should also bear
in mind that the data in Table 1 refer to formal second-
ary diagnoses made by the treating clinical team.
Although lower than expected, alcohol use/dependence
was one of the most common secondary diagnoses in
BD suicides and therefore may have been an important
contributory factor. Less than 40% of BD suicides had
evidence of depressive symptoms at their last contact
with services before the suicide. This is in contrast to
many studies of suicide attempt in BD, where struc-
tured psychiatric assessments have found that depres-
sive symptoms and depressive episode are prominent.
The lower than expected proportion of cases with
depression in our results could be due to the particular
characteristics of our clinical sample, a reflection of the
time interval between being seen and death, or it could
be an indication of a crucial under-recognition of de-
pression among this group. Risk of suicide is thought
to be higher at younger ages and earlier in the course
Table 3. Clinical characteristics at last contact with mental health services for suicides with a primary diagnosis of bipolar disorder (BD)
compared to suicides with any other primary diagnosis








n (%) OR (95% CI) p value
Time between last contact and suicide (97)
<24 h 349 (23.7) 2589 (19.2) 1.30 (1.15–1.48) <0.01
1–7 days 555 (37.6) 3988 (29.6) 1.43 (1.28–1.60)
1–4 weeks 312 (21.2) 3153 (23.4) 0.88 (0.77–1.00)
5–13 weeks 151 (10.2) 1746 (13.0) 0.77 (0.65–0.91)
>13 weeks 108 (7.3) 1984 (14.7) 0.46 (0.37–0.56)
Evidence of emotional distress (94) 467 (32.3) 4565 (34.8) 0.90 (0.80–1.01) 0.07
Evidence of depressive episode (94) 567 (39.2) 3859 (29.5) 1.54 (1.38–1.72) <0.01
Evidence of hostility (94) 62 (4.3) 786 (6.0) 0.70 (0.54–0.92) 0.01
Evidence of hopelessness (93) 229 (16.0) 1950 (15.1) 1.07 (0.92–1.24) 0.39
Immediate suicide risk (92)
No risk 417 (29.2) 3842 (30.0) 0.96 (0.85–1.09) 0.64
Low 813 (57.0) 7162 (56.0) 1.04 (0.93–1.16)
Moderate 173 (12.1) 1520 (11.9) 1.02 (0.87–1.21)
High 24 (1.7) 270 (2.1) 0.79 (0.52–1.21)
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of BD (Goodwin & Jamison, 1990). However, our
results show that BD suicides commonly took place
more than 5 years post-diagnosis and most frequently
by people in the 25–64-year age groups, and suicides
by people aged between 45 and 64 years were much
more common in the BD group than in the other pri-
mary diagnosis group. We found that the majority of
cases included were considered to be at ‘low risk’ for
suicide at last contact with services. This is consistent
with the results of psychological autopsy studies,
which have shown that suicidal intent is rarely com-
municated when the individual is seen by a health-care
professional shortly before the suicidal act, although it
may be communicated earlier to friends or family
members (Isometsä et al. 1994, 1995).
Methodological issues
Not all those with BD who die by suicide will be in
contact with services in the 12 months before death
(Merikangas & Pato, 2009), and not all those in contact
with services will be appropriately diagnosed with
BD (Dunner, 2003; Benazzi, 2006). The characteristics
of our sample may not reflect the characteristics of
those with BD with no service contact prior to death.
A study from The Netherlands by ten Have et al.
(2002) found that the most common reason for a lack
of contact with mental health services was lower sev-
erity of BD symptoms; therefore our sample may be
biased towards the more seriously ill. It would have
not been feasible as part of this national study to collect
detailed data on all individuals with BD who had not
been in contact with mental health services.
Data used in the analyses were collected from clini-
cians after the suicide had occurred. Completion of the
NCI suicide questionnaire relies on the accuracy of
case-notes and the clinicians’ knowledge of the patient.
The clinicians were therefore not blind to patient out-
come when completing the questionnaire and it is pos-
sible that this could influence results, particularly those
relating to care or treatment before death.
Allocation to the BD suicide group was dependent
on the recording of primary diagnosis by responding
clinicians and it is possible that, where there were mul-
tiple co-morbidities, primacy may have been attributed
incorrectly. There were 89 cases with a secondary diag-
nosis of BD, all of which had a primary diagnosis of
schizophrenia; we adopted a conservative approach
and included these in the other primary diagnosis
group, which may have reduced between-group differ-
ences. We also carried out a post-hoc sensitivity analysis
including these 89 individuals in our BD suicide group.
There was little effect overall on the results.
It is possible that the clinician completing the ques-
tionnaire was not the professional with whom the
last contact was made and consequently variables
relating to clinical state might have been under-
reported and found less frequently than expected
(e.g. evidence of depressive symptoms). However, clin-
icians generally use patient records along with their
personal knowledge and recollection of the patient
when filling in the NCI questionnaire, and it would
be unusual for significant changes in mood state not
to be recorded as part of the clinical record.
There are some potential issues with missing data on
the NCI database and therefore the results presented
should be interpreted with caution. The majority of
variables were more than 90% complete. Patient treat-
ment variables had greater levels of missing data. In
most cases this was because the clinician completing
the questionnaire left some fields blank, but some
cases were historical artefacts due to the evolving
nature of the suicide questionnaire and the addition
of new questions over time that could not be back-
coded for older cases (these have been adjusted
where possible; for example, access to drug and alco-
hol services was added in 2003).
This study was descriptive in nature. Although it
was possible to identify characteristics that are com-
mon in suicide in BD, it was not possible to comment
on the aetiology of these factors, or inter-relationships
that may exist between them. As some of these risk
factors may have been consequences of care and not
true risk factors, we did not undertake a multivariate
analysis.
Clinical and research implications
Frequency and characteristics of suicide in BD
Suicide prevention is a priority for services (Appleby
et al. 2012). The results of this study show that those
with BD frequently die by suicide, and our findings
are likely to have underestimated the magnitude of
this risk. Overall, the frequency of bipolar suicide
seems to have remained relatively stable over time,
which is in contrast to falling rates of suicide in the
English general population. It may be that some of
the societal determinants of suicide have less of an
impact in this clinical population, where illness-related
factors may be more relevant. The possibility that indi-
vidual clinical groups are not benefiting from an over-
all decline in suicide raises issues of equity and this
warrants specific exploration in future studies. Never-
theless, the lack of a significant decrease in suicide
rates by those with BD could be a power issue reflect-
ing the comparatively small numbers of deaths in this
group. The evident stability of BD suicide deaths could
also be a consequence of the improved diagnosis of BD
and perhaps of BD II in particular. This might have
caused an increase in BD suicides as people who
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would previously have been diagnosed with unipolar
depressive disorder are moved into the BD category.
Although several demographic and social character-
istics in our BD sample were similar to those in sui-
cides in general and psychiatric populations, we did
find that women were over-represented. There is little
consensus on the role of gender in relation to suicide
in BD, and this might reflect a greater long-term sui-
cide risk in women than in men (Pompili et al. 2009;
Gonda et al. 2012). Cohort studies of those with mental
illness often describe the risk of suicide as highest at
the time of diagnosis, with the risk subsequently
diminishing over time (Goodwin & Jamison, 1990;
ten Have et al. 2002). We found that the majority of
BD suicides in fact took place at least 5 years after diag-
nosis. In addition, those with BD were more likely
to die by suicide in middle-age than those with other
primary diagnoses. These findings suggest that risk
of suicide in BD may be relatively persistent.
Implications for services and treatment
Although there were similar levels of co-morbid alco-
hol dependence in the BD group and in those with
other primary diagnoses, the BD group were less likely
to be in contact with alcohol services, highlighting a
possible deficiency in the provision of dual diagnosis
services. However, policy changes have sought to ad-
dress this (Department of Health, 2001; CSIP, 2008).
Over a third of BD suicides in this study were not pre-
scribed lithium or another mood stabilizer, although
there were some missing data for this variable. Given
the increased risk of suicide that seems to accompany
a diagnosis of BD and the strong evidence for the pro-
tective effect of lithium (Tondo et al. 2003; Angst et al.
2005; Rihmer, 2005), this might be considered a key
treatment in long-term management.
Risk assessment
A clinically important result was that the majority of
patients with BD were seen by mental health services
during the week before the suicide, and nearly a
quarter within the 24 hours immediately preceding it,
providing a potential opportunity for services to inter-
vene. However, nine out of 10 BD suicides were as-
sessed as being at no or low risk at last contact.
These data suggest that clinical assessment of suicide
risk may not be accurately identifying at-risk BD
patients, or that patients with BD are subject to rapid
changes in mental state consistent with the hypothesis
that suicidal behaviour in BD is associated with impul-
sivity (Rihmer, 2007). However, assessment of suicide
risk reported on the NCI questionnaire may also be
influenced by other considerations such as recall bias,
defensiveness in the reporting of this item, or the result
of adaptation to risk by clinical staff through continued
exposure to high-risk patients. It is also possible that
recognition of high risk could trigger the implement-
ation of interventions to lessen that risk and thereby
prevent suicide, and so by default the majority of com-
pleted suicides by psychiatric patients in contact with
services would be from individuals not identified as
being at risk. Although this explanation is heuristically
appealing, questions remain regarding why these cases
of completed suicide were not assessed as ‘at risk’, and
whether there are indicators of risk that are being
missed in current assessments.
It is important that health professionals are able to
accurately identify those patients who might be most
at risk. Factors such as alcohol dependence/misuse,
personality disorder, depressive episode, multiple
psychiatric admissions and current or recent admission
could characterize such a high-risk group. In our
sample of BD suicide deaths, 75% had one or more of
these factors, 34% had two or more, 8% had three or
more, and less than 1% had four. In terms of risk
management, a reduction in the emphasis placed on tra-
ditional indicators of risk, such as social circumstances
and recent diagnosis, and an increase in the emphasis
on diagnosis-specific factors may increase the utility of
assessments. Ideally, clinically useful indicators of sui-
cide risk that can be operationalized need to be iden-
tified in future studies. However, the identification
of a high-risk group with BD on the basis of factors
associated with suicide in this sample would be prema-
ture as two-thirds of completed suicide had less than
two of these risk factors. Morework is required to deter-
mine the causes of suicide in BD and to explore how risk
factors interact to precipitate suicidal behaviour.
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